A panel of FDA advisers voted unanimously in favor of approving Novartis’ new anti-inflammatory treatment, an expected positive outcome for the company as it races to be first in line among what promises to be a crowded field.

…read more

Source: Novartis clears an FDA hurdle with its pioneering psoriasis treatment


0 No comments